Literature DB >> 22195561

A small molecule discrimination map of the antibiotic resistance kinome.

Tushar Shakya1, Peter J Stogios, Nicholas Waglechner, Elena Evdokimova, Linda Ejim, Jan E Blanchard, Andrew G McArthur, Alexei Savchenko, Gerard D Wright.   

Abstract

Kinase-mediated resistance to antibiotics is a significant clinical challenge. These enzymes share a common protein fold characteristic of Ser/Thr/Tyr protein kinases. We screened 14 antibiotic resistance kinases against 80 chemically diverse protein kinase inhibitors to map resistance kinase chemical space. The screens identified molecules with both broad and narrow inhibition profiles, proving that protein kinase inhibitors offer privileged chemical matter with the potential to block antibiotic resistance. One example is the flavonol quercetin, which inhibited a number of resistance kinases in vitro and in vivo. This activity was rationalized by determination of the crystal structure of the aminoglycoside kinase APH(2″)-IVa in complex with quercetin and its antibiotic substrate kanamycin. Our data demonstrate that protein kinase inhibitors offer chemical scaffolds that can block antibiotic resistance, providing leads for co-drug design.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22195561     DOI: 10.1016/j.chembiol.2011.10.018

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  25 in total

1.  Structural basis for dual nucleotide selectivity of aminoglycoside 2''-phosphotransferase IVa provides insight on determinants of nucleotide specificity of aminoglycoside kinases.

Authors:  Kun Shi; Albert M Berghuis
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

2.  Structure-guided optimization of protein kinase inhibitors reverses aminoglycoside antibiotic resistance.

Authors:  Peter J Stogios; Peter Spanogiannopoulos; Elena Evdokimova; Olga Egorova; Tushar Shakya; Nick Todorovic; Alfredo Capretta; Gerard D Wright; Alexei Savchenko
Journal:  Biochem J       Date:  2013-09-01       Impact factor: 3.857

3.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

4.  Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes.

Authors:  Peter Spanogiannopoulos; Maulik Thaker; Kalinka Koteva; Nicholas Waglechner; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

6.  Calyculin biogenesis from a pyrophosphate protoxin produced by a sponge symbiont.

Authors:  Toshiyuki Wakimoto; Yoko Egami; Yu Nakashima; Yukihiko Wakimoto; Takahiro Mori; Takayoshi Awakawa; Takuya Ito; Hiromichi Kenmoku; Yoshinori Asakawa; Jörn Piel; Ikuro Abe
Journal:  Nat Chem Biol       Date:  2014-06-29       Impact factor: 15.040

Review 7.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

Review 8.  Strategies to overcome the action of aminoglycoside-modifying enzymes for treating resistant bacterial infections.

Authors:  Kristin J Labby; Sylvie Garneau-Tsodikova
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

9.  FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules.

Authors:  Hongyi Zhou; Hongnan Cao; Jeffrey Skolnick
Journal:  J Chem Inf Model       Date:  2018-10-16       Impact factor: 4.956

10.  Raf-kinase inhibitor GW5074 shows antibacterial activity against methicillin-resistant Staphylococcus aureus and potentiates the activity of gentamicin.

Authors:  Tatiana Johnston; Gabriel Lambert Hendricks; Steven Shen; Roy Fangxing Chen; Bumsup Kwon; Michael John Kelso; Wooseong Kim; Beth Burgwyn Fuchs; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-09-21       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.